학술논문
OAD-Treated Type 2 Patients Initiated on Insulin Detemir Experience Significant Weight Loss when SU or TZD Are Discontinued at Insulin Initiation: Results from PREDICTIVE™.
Document Type
Article
Source
Subject
*TYPE 2 diabetes treatment
*PEOPLE with diabetes
*HYPOGLYCEMIC agents
*HYPOGLYCEMIC sulfonylureas
*WEIGHT loss
*EUROPEANS
*DISEASES
INSULIN therapy effectiveness
*
*
*
*
*
*
Language
ISSN
0012-1797
Abstract
The article focuses the findings of the PREDICTIVE study that evaluated the efficacy of insulin detemir initiation on oral antidiabetic agent (OAD)-treated type 2 diabetic patients. Data from poorly controlled OAD-treated insulin naive type 2 diabetics from the European cohort was analyzed. The subjects were grouped into two including those treated with metformin (MET) and sulphonylureas and those treated with thiazolidinediones (TZD). The discontinuance of SU and TZD resulted in weight loss.